Breathe Better,
Live Smarter

Innovating Respiratory Health for a Better Tomorrow

At Breethwell, we are transforming the understanding and management of respiratory health. Our groundbreaking CMAP technology (Continuously Monitoring Airway Pressure) addresses critical issues like Day Apnea®, Screen Apnea®, and other breathing-related conditions, paving the way for new research, therapeutic applications, and wellness opportunities.

Why Choose CMAP?

Innovative Technology

The CMAP device is powered by state-of-the-art airflow sensors and advanced pulse oximetry, delivering unparalleled accuracy in monitoring nasal and oral breathing patterns, heart rate, and oxygen saturation levels. This innovative technology captures real-time data with precision, translating it into actionable insights.

Proven Effectiveness

Clinically proven to address screen apnea, anxiety, and hypertension. Offers licensing, franchising, and cross-promotional opportunities for businesses and professionals.

Real-Time Monitoring

The CMAP transmits data via Bluetooth/WiFi to mobile devices for display, analysis, alerts, and coaching. The Speaker and Haptic Motor provide user communication and alerts.

Versatile Configurations

The CMAP offers multiple model configurations: 1 Pressure Sensor – 1 cannula port; 2 Pressure Sensors – 2 cannula ports; Oximetry Sensor with Pulse Heart Rate only; Oximetry Sensor with Pulse Heart Rate and SpO2.

Sync With Apps

CMAP pairs seamlessly with top breathwork apps (like Breathwrk or Othership) for guided exercises. Track real-time breathing, heart rate, and SpO2—no proprietary app needed. Just sync and breathe smarter.

Research Applications

Supports respiratory studies and clinical diagnostics with detailed waveform analysis. Enables tailored insights into breathing-related health conditions.

Who is CMAP For?

Professionals

Addresses Screen Apnea®—a phenomenon where 40% of people unconsciously hold their breath during screen use, reducing focus and increasing stress.

Athletes

Optimizes breathing patterns for peak performance, endurance, and faster recovery through real-time SpO2 and respiration monitoring.

Medical Community

Provides clinicians with accurate data to diagnose and manage conditions like hypertension, anxiety, and respiratory disorders.

Researchers

Enables large-scale respiratory studies with IoT-enabled, high-precision waveform analysis.

Everyone

Promotes healthier breathing habits to enhance sleep, energy, and overall well-being.

Investment Opportunity

Revolutionizing Respiratory Health Technology

1. Huge Market Potential
  • Targets $12 billion hypertension device market
  • Part of $4.9 trillion global wellness industry
2. Proven Revenue Model
  • Device sales: 299−499 per unit
  • Recurring revenue: Sensor replacements & accessories
  • Licensing deals: Partnerships with health apps
3. Clinical Proof
  • Reduces Screen Apnea® by 70% in users
  • FDA clearance pathway for hypertension treatment
4. Competitive Advantage
  • 7 patents pending on unique airflow technology
  • More accurate than chest-band alternatives

Hear From Our Users